Ensysce Biosciences Reports Third Quarter 2026 Financial and Operational Results
Ensysce Biosciences announced its financial results for the third quarter ended September 30, 2026, highlighting the impact of its recent Cy Biopharma acquisition and progress in its clinical pipeline.